首页> 外文期刊>Cell biology international. >SARS‐CoV‐2 vaccines: A double‐edged sword throughout rapid evolution of COVID‐19
【24h】

SARS‐CoV‐2 vaccines: A double‐edged sword throughout rapid evolution of COVID‐19

机译:SARS‐CoV‐2 vaccines: A double‐edged sword throughout rapid evolution of COVID‐19

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract After more than 2 years of the coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus 2, several questions have remained unanswered that affected our daily lives. Although substantial vaccine development could resist this challenge, emerging new variants in different countries could be considered as potent concerns regarding the adverse effects of reinfection or postvaccination. Precisely, these concerns address some significant and probable outcomes in vaccinated or reinfected models, followed by some virus challenges, such as antibody‐dependent enhancement and cytokine storm. Therefore, the importance of evaluating the effectiveness of neutralizing antibodies (nAbs) elicited by vaccination and the rise of new variants must be addressed.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号